SCHEMBL6919673

SCHEMBL6919673

CCCc1nn(C)c(O)c1C(=O)c1ccccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
NR2F2 P24468 1/20 0.38
PAX8 Q06710 1/20 0.38
KLF5 Q13887 1/20 0.38
LMNA P02545 5/20 0.38
KDM4E B2RXH2 5/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
HTT P42858 3/20 0.38
NAPRT Q6XQN6 1/20 0.37
P4HTM Q9NXG6 1/20 0.37
USP2 O75604 1/20 0.37
HSD17B14 Q9BPX1 1/20 0.36
PDE5A O76074 1/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921028 0.84 P2RX7 (0.38) ALDH1A1NPC1RAB9ACES1LMNA
SCHEMBL6919650 0.80 KMT2A (0.46) KMT2AALDH1A1NPC1RAB9ACES2
SCHEMBL2214214 0.77 ALDH1A1 (0.43) ALDH1A1LMNAL3MBTL1HTTGAA
SCHEMBL6919753 0.76 TDP1 (0.48) KMT2AALDH1A1KDM4EGAAMAPT
SCHEMBL6919835 0.71 L3MBTL1 (0.47) KMT2AALDH1A1NPC1RAB9ALMNA
Alcohol SCHEMBL9405122 0.69 KMT2A (0.62) KMT2AALDH1A1NPC1RAB9ACES2
SCHEMBL6916937 0.68 HCAR2 (0.41) ALDH1A1NPC1RAB9ALMNAKDM4E
Propylamine SCHEMBL28734534 0.68 KMT2A (0.56) KMT2AALDH1A1NPC1RAB9ACES2
SCHEMBL23399929 0.66 PDE5A (0.45) KMT2AALDH1A1NPC1RAB9ALMNA
SCHEMBL87791 0.66 KMT2A (0.75) KMT2AALDH1A1NPC1RAB9ACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004033431-A2 HYDROXYPYRAZOLES FOR USE AGAINST METABOLIC-RELATED DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2004-04-22 WO claimed
WO-2004033431-A2 HYDROXYPYRAZOLES FOR USE AGAINST METABOLIC-RELATED DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2004-04-22 WO disclosed